Duquesne University and CVS Pharmacy have launched a new initiative to support CVS employees pursuing a Doctor of Pharmacy degree through Duquesne's online pharmacy program. 

Merck & Co.'s heavy reliance on its cancer drug Keytruda, which accounts for nearly half of the company's revenue, is raising investor concerns as the drug's patent expiration approaches in 2028, The Wall Street Journal reported Feb. 5. 

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. 

Merck's 2025 revenue forecast fell short of Wall Street expectations, following the company's decision to temporarily halt shipments of its cancer vaccine, Gardasil, to China, CNBC reported Feb. 4. 

In 2024, an average of 74.1% pharmacy school graduates passed the North American Pharmacist Licensure Examination, according to the National Association of Boards of Pharmacy. 

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain. 

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street Journal reported Jan. 28. 

While the American Society of Health-System Pharmacists largely supports CMS' proposed policy revisions for Medicare Part D, Medicare Advantage and the program of all-inclusive care for the elderly, or PACE, the ASHP is asking the agency to "change course" on…

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in The New England Journal of Medicine. 

To alleviate healthcare access strains, Intermountain Health is broadening its on-demand pharmacy and lab services, ABC4 Utah reported Jan. 28.